{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:57:34Z","timestamp":1789095454864,"version":"build-2803163510"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:p>The diagnosis of Ewing sarcoma can be challenging, particularly when the tumor is present in an atypical location and resembles histologic mimics. The hallmark feature of Ewing sarcoma is chromosomal translocation, t(11;22)(q24;q12), involving <jats:italic toggle=\"yes\">EWSR1<\/jats:italic> and <jats:italic toggle=\"yes\">ETS<\/jats:italic> gene family members. For decades, fluorescence in situ hybridization with a break-apart <jats:italic toggle=\"yes\">EWSR1<\/jats:italic> probe has been the diagnostic gold standard. However, <jats:italic toggle=\"yes\">EWSR1<\/jats:italic> rearrangements have been identified in other malignancies; thus, the detection of chimeric <jats:italic toggle=\"yes\">EWSR1<\/jats:italic> transcripts has become a preferable approach. Occasionally, insufficient tissue, severe RNA degradation, or economic constraints hamper molecular testing. This study evaluated Protein Kinase C Beta II (PKC \u03b2 II) expression in &gt;1000 tumors and assessed the utility of PKC \u03b2 II immunohistochemistry in the differential diagnosis of Ewing sarcoma. Tumors harboring <jats:italic toggle=\"yes\">EWSR1<\/jats:italic>::<jats:italic toggle=\"yes\">FLI1<\/jats:italic> (n=26), <jats:italic toggle=\"yes\">EWSR1<\/jats:italic>::<jats:italic toggle=\"yes\">ERG<\/jats:italic>, <jats:italic toggle=\"yes\">EWSR1<\/jats:italic>::<jats:italic toggle=\"yes\">ETV4<\/jats:italic> (n=1), and <jats:italic toggle=\"yes\">FUS<\/jats:italic>::<jats:italic toggle=\"yes\">ERG<\/jats:italic> (n=6) fusions were evaluated, revealing strong diffuse immunoreactivity, although a patchy pattern was seen in 3 cases. Undifferentiated round cell sarcomas (n=46), including <jats:italic toggle=\"yes\">BCOR<\/jats:italic>-, <jats:italic toggle=\"yes\">CIC<\/jats:italic>-, <jats:italic toggle=\"yes\">NFATC2<\/jats:italic>-, <jats:italic toggle=\"yes\">NUTM1<\/jats:italic>-, and <jats:italic toggle=\"yes\">PATZ1<\/jats:italic> rearranged\/fusion-sarcomas were negative. Two of the 130 synovial sarcomas, including 1 with a poorly differentiated morphology, showed diffuse, moderate-to-strong positivity. One of the 26 poorly differentiated carcinomas from the head and neck region, probably small cell lung carcinoma metastasis, showed strong PKC \u03b2 II expression. Neuroblastomas (&gt;50%) expressed PKC \u03b2 II, although none showed a strong diffuse pattern. Diffuse moderate-to-strong immunoreactivity was observed in 2 sarcomatoid mesotheliomas and 2 metastatic melanomas. Diffuse but weak staining was observed in 73% (11\/15) of the T-cell lymphoblastic lymphomas, including 10 CD99-positive cases. Similarly, weak predominantly patchy staining was seen in half (40\/80) of other non-Hodgkin lymphomas and sporadically in embryonal rhabdomyosarcoma, Merkel cell carcinoma, small cell lung carcinoma, and Wilms tumor. Thus, diffuse and strong PKC \u03b2 II immunoreactivity appears to be a reliable diagnostic marker for distinguishing classic Ewing sarcoma from histologic mimics.<\/jats:p>","DOI":"10.1097\/pas.0000000000002400","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T04:00:08Z","timestamp":1744689608000},"page":"800-806","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Utility of Protein Kinase C Beta II Immunohistochemistry in Differential Diagnosis of Ewing Sarcoma"],"prefix":"10.1097","volume":"49","author":[{"given":"Jerzy","family":"Lasota","sequence":"first","affiliation":[{"name":"Laboratory of Pathology, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyna","family":"Krupi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital of the Canary Islands, San Crist\u00f3bal de La Laguna, Santa Cruz de Tenerife, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Kaczorowski","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, National Cancer Institute, Bethesda, MD"},{"name":"Department of Clinical and Experimental Pathology, Wroc\u0142aw Medical University, Wroc\u0142aw"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Ch\u0142opek","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, National Cancer Institute, Bethesda, MD"},{"name":"Department of Molecular Diagnostics, Holycross Cancer Center, Kielce, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenek","family":"Kinkor","sequence":"additional","affiliation":[{"name":"Bioptick\u00e1 Laborato\u0159 Ltd., Pilsen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"\u0160vajdler","sequence":"additional","affiliation":[{"name":"Bioptick\u00e1 Laborato\u0159 Ltd., Pilsen"},{"name":"Department of Pathology, Faculty of Medicine in Plzen, University Hospital Plzen, Charles University, Plzen, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Perret","sequence":"additional","affiliation":[{"name":"Department of Pathobiology, Institut Bergoni\u00e9, Comprehensive Cancer Center, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory W.","family":"Charville","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Bradov\u00e1","sequence":"additional","affiliation":[{"name":"Bioptick\u00e1 Laborato\u0159 Ltd., Pilsen"},{"name":"Department of Pathology, Faculty of Medicine in Plzen, University Hospital Plzen, Charles University, Plzen, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"Ylaya","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Weso\u0142owska","sequence":"additional","affiliation":[{"name":"Department of Tumor Pathology, Maria Sk\u0142odowska-Curie National Research Institute of Oncology, Cracow Branch, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Rozmus-Pi\u0119to\u0144","sequence":"additional","affiliation":[{"name":"Department of Tumor Pathology, Maria Sk\u0142odowska-Curie National Research Institute of Oncology, Cracow Branch, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Ry\u015b","sequence":"additional","affiliation":[{"name":"Department of Tumor Pathology, Maria Sk\u0142odowska-Curie National Research Institute of Oncology, Cracow Branch, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Michal","sequence":"additional","affiliation":[{"name":"Bioptick\u00e1 Laborato\u0159 Ltd., Pilsen"},{"name":"Department of Pathology, Faculty of Medicine in Plzen, University Hospital Plzen, Charles University, Plzen, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Michal","sequence":"additional","affiliation":[{"name":"Bioptick\u00e1 Laborato\u0159 Ltd., Pilsen"},{"name":"Department of Pathology, Faculty of Medicine in Plzen, University Hospital Plzen, Charles University, Plzen, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Miettinen","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"R1-20250728","first-page":"17","article-title":"Diffuse endothelioma of bone","volume":"12","author":"Ewing","year":"1921","journal-title":"Proc New York Pathol Soc"},{"key":"R2-20250728","first-page":"2","article-title":"A tumor of the ulnar nerve","volume":"18","author":"Stout","year":"1918","journal-title":"Proc NY Pathol Soc"},{"key":"R3-20250728","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1002\/1097-0142(197906)43:6<2438::AID-CNCR2820430640>3.0.CO;2-9","article-title":"Malignant small cell tumor of the thoracopulmonary region in childhood: a distinctive clinicopathologic entity of uncertain histogenesis","volume":"43","author":"Askin","year":"1979","journal-title":"Cancer"},{"key":"R4-20250728","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0165-4608(84)90003-7","article-title":"Translocation involving chromosome 22 in Ewing\u2019s sarcoma. A cytogenetic study of four fresh tumors","volume":"12","author":"Aurias","year":"1984","journal-title":"Cancer Genet Cytogenet"},{"key":"R5-20250728","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-4608(86)90001-4","article-title":"Cytogenetic characterization of selected small round cell tumors of childhood","volume":"21","author":"Whang-Peng","year":"1986","journal-title":"Cancer Genet Cytogenet"},{"key":"R6-20250728","first-page":"1294","article-title":"Detection of the (11;22)(q24;q12) translocation of Ewing\u2019s sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction","volume":"143","author":"Downing","year":"1993","journal-title":"Am J Pathol"},{"key":"R7-20250728","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/359162a0","article-title":"Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours","volume":"359","author":"Delattre","year":"1992","journal-title":"Nature"},{"key":"R8-20250728","first-page":"1621","article-title":"The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing\u2019s sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members","volume":"8","author":"Zhang","year":"1993","journal-title":"Oncogene"},{"key":"R9-20250728","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/jcp.56.2.96","article-title":"Ewing\u2019s sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities","volume":"56","author":"Burchill","year":"2003","journal-title":"J Clin Pathol"},{"key":"R10-20250728","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/modpathol.2016.31","article-title":"Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma","volume":"29","author":"Hung","year":"2016","journal-title":"Mod Pathol"},{"key":"R11-20250728","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.prp.2017.08.002","article-title":"Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors","volume":"213","author":"Machado","year":"2017","journal-title":"Pathol Res Pract"},{"key":"R12-20250728","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/cncy.22056","article-title":"NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: diagnostic utility and pitfalls","volume":"126","author":"Russell-Goldman","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"R13-20250728","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/15513815.2022.2117579","article-title":"Validation of PRKCB immunohistochemistry as a biomarker for the diagnosis of Ewing sarcoma","volume":"42","author":"Zota","year":"2023","journal-title":"Fetal Pediatr Pathol"},{"key":"R15-20250728","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1097\/PAS.0000000000001944","article-title":"PRAME expression in cancer. A Systematic immunohistochemical study of >5800 epithelial and nonepithelial tumors","volume":"46","author":"Kaczorowski","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R16-20250728","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/oxfordjournals.jbchem.a003273","article-title":"Protein kinase C beta (PKC beta): normal functions and diseases","volume":"132","author":"Kawakami","year":"2002","journal-title":"J Biochem"},{"key":"R17-20250728","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1158\/0008-5472.CAN-12-0371","article-title":"Targeting the EWSR1-FLI1 oncogene-induced protein kinase PKC-\u03b2 abolishes Ewing sarcoma growth","volume":"72","author":"Surdez","year":"2012","journal-title":"Cancer Res"},{"key":"R18-20250728","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/35099076","article-title":"The ETS-domain transcription factor family","volume":"2","author":"Sharrocks","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R19-20250728","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/PAS.0000000000001447","article-title":"A novel SS18-SSX fusion-specific antibody for the diagnosis of synovial sarcoma","volume":"44","author":"Baranov","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R20-20250728","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/his.14190","article-title":"When used together SS18-SSX fusion-specific and SSX C-terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most cases","volume":"77","author":"Zaborowski","year":"2020","journal-title":"Histopathology"},{"key":"R21-20250728","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/PAS.0000000000002144","article-title":"Utility of immunohistochemistry with antibodies to SS18-SSX chimeric proteins and C-terminus of SSX protein for synovial sarcoma differential diagnosis","volume":"48","author":"Lasota","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"R22-20250728","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/01.pas.0000167056.13614.62","article-title":"Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases","volume":"29","author":"Folpe","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R23-20250728","doi-asserted-by":"crossref","first-page":"153362","DOI":"10.1016\/j.prp.2021.153362","article-title":"Neuroendocrine differentiation in a large series of genetically-confirmed Ewing\u2019s sarcoma family tumor: does it provide any diagnostic or prognostic information?","volume":"219","author":"Machado","year":"2021","journal-title":"Pathol Res Pract"},{"key":"R24-20250728","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00428-024-03926-1","article-title":"TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entities","volume":"485","author":"M\u00f6ller","year":"2024","journal-title":"Virchows Arch"},{"key":"R25-20250728","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1038\/ncomms5846","article-title":"The landscape of kinase fusions in cancer","volume":"5","author":"Stransky","year":"2014","journal-title":"Nat Commun"},{"key":"R26-20250728","doi-asserted-by":"crossref","first-page":"100286","DOI":"10.1016\/j.modpat.2023.100286","article-title":"Histologic and genetic features of 51 melanocytic neoplasms with protein kinase C fusion genes","volume":"36","author":"de la Fouchardi\u00e8re","year":"2023","journal-title":"Mod Pathol"},{"key":"R27-20250728","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1097\/PAS.0000000000002262","article-title":"PRKC fusion melanocytic tumors, a subgroup of melanocytic tumors more closely aligned to blue nevi than to PRKAR1A-inactivated pigmented epithelioid melanocytomas","volume":"48","author":"Patel","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"R28-20250728","first-page":"1047","article-title":"Protein kinase C at the crossroad of mutations, cancer, targeted therapy and immune response","volume":"12","author":"Aquino","year":"2023","journal-title":"Biology (Basel)"},{"key":"R29-20250728","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3390\/pharmaceutics13111748","article-title":"Activators and inhibitors of protein kinase C (PKC): their applications in clinical trials","volume":"13","author":"Kawano","year":"2021","journal-title":"Pharmaceutics"},{"key":"R30-20250728","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41416-022-02133-6","article-title":"A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma","volume":"128","author":"Piperno-Neumann","year":"2023","journal-title":"Br J Cancer"},{"key":"R31-20250728","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/pbc.23040","article-title":"Risk of recurrence and survival after relapse in patients with Ewing sarcoma","volume":"57","author":"Stahl","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R32-20250728","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1182\/blood-2019-128871","article-title":"The protein kinase C inhibitor MS-553 for the treatment of chronic lymphocytic leukemia","volume":"134","author":"Muhowski","year":"2019","journal-title":"Blood"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T11:00:14Z","timestamp":1753700414000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002400","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]}}}